Progression and Outcomes of Oral Submucous Fibrosis: Insights from a Case Series
Main Article Content
Abstract
In India, tobacco consumption—particularly in the form of chewing—is deeply entrenched in daily life. It is not uncommon for at least one member in a household to engage in this habit, either occasionally or regularly. Despite widespread awareness of its harmful ingredients, tobacco continues to be used for various reasons, including recreation, stress relief, and taste preference. Among the many health consequences linked to the habitual chewing of tobacco and areca nut, Oral Submucous Fibrosis (OSMF) has emerged as a significant and increasingly encountered clinical condition. OSMF often presents not only in its classical form but also with varied and sometimes masked clinical appearances, making early diagnosis challenging.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Nair, R. G., & Nair, P. M. (2016). Oral submucous fibrosis: A comprehensive review. Journal of Cancer Research and Therapeutics, 12(1), 65-69.
II. Yada, S., & Sood, S. (2017). Oral submucousfibrosis: A review. International Journal of Oral Care and Research, 5(3), 133-137.
III. Ramesh, N., & Bhaskar, D. (2021). The role of oxidative stress and DNA damage in the pathogenesis of OSMF. Oral Oncology, 60, 65-72.
IV. Rajendran, R., & Sivapathasundaram, B. (2018). Shafer’s Textbook of Oral Pathology (8th ed.). Elsevier.
V. Krishnan, S. K., Bhat, V. S., & Srinivasan, T. K. S. (2021). Oral submucous fibrosis: Etiology, pathogenesis, and treatment. Journal of Oral Pathology & Medicine, 39(5), 399-406.
VI. Chatterjee, S., & Basak, S. (2019). Genetic and environmental factors in the development of oral submucous fibrosis: A review. International Journal of Oral and Maxillofacial Surgery, 48(8), 1015-1023.
VII. Sharma, P., & Goyal, M. (2019). Oral submucous fibrosis: An overview. Journal of Clinical and Diagnostic Research, 13(5), 19-23.
VIII. Bansal, S. (2021). A review of clinical and histopathological features of oral submucousfibrosis. Journal of Cancer Research & Therapeutics, 17(5), 1078-1084.
IX. Pathak, S. K., & Koirala, B. (2020). Clinical features and diagnostic approach of oral submucous fibrosis. Asian Journal of Oral and Maxillofacial Surgery, 27(4), 179-185.
X. Gaba, S. (2015). Clinical and histopathological diagnosis of oral submucousfibrosis. International Journal of Oral Health and Medical Research, 2(3), 72-76.
XI. Pindborg, J. J. (2003). Oral submucousfibrosis. Journal of Oral Pathology & Medicine, 32(6), 263-267.
XII. Saha, M. K., & Saha, P. (2019). Imaging techniques in the diagnosis and management of oral submucous fibrosis. Journal of Oral and Maxillofacial Imaging, 5(1), 20-26.
XIII. Shah, N. (2019). Management strategies for oral submucous fibrosis: A comprehensive review. Indian Journal of Dental Research, 30(3), 301-308.
XIV. Saini, R., & Saini, S. (2021). Stem cell-based regenerative therapy for oral submucousfibrosis: A systematic review. Stem Cells International, 2021, 6374947.
XV. Nair, U. M., & Ranganathan, K. (2016). Malignant transformation in oral submucousfibrosis: A retrospective study. Journal of Oral Pathology & Medicine, 45(8), 597-602.
XVI. Fathima, S., & Bhagyalakshmi, S. (2017). Malignant transformation of oral submucousfibrosis: A clinicopathological study. Journal of Clinical and Diagnostic Research, 11(3), 07-10.
XVII. Gupta, S. S., & Sharma, S. (2020). Predictive biomarkers for the malignant transformation of oral submucous fibrosis. Oral Oncology, 107, 104770.